INDIA: India May Begin AIDS Vaccine Trials in Mid-2004

Important note: Information in this article was accurate in 2003. The state of the art may have changed since the publication date.

INDIA: India May Begin AIDS Vaccine Trials in Mid-2004

Reuters (12.17.03) - Wednesday, December 17, 2003

India will likely begin the first phase of clinical trials of an indigenously developed AIDS vaccine by the middle of 2004, the president of the New York-based International AIDS Vaccine Initiative said today. "Globally, vaccines are on trial in many countries including the US and South Africa. Soon they should start in Rwanda and thereafter in India and eventually China," Seth Berkley told reporters. "The real challenge after phase one trials begin in the middle of next year is to move into efficacy trials quickly." The Indian government has been working with IAVI on developing an AIDS vaccine for HIV strain C, the most common sub-type in India. India has about 4.58 million HIV-infected people, and experts say the country could surpass South Africa, which has the highest infection rate worldwide, in absolute numbers in the next few years.
031217
AD032625

Copyright © 2003 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.